Human diversity in killer cell inhibitory receptor genes.

[1]  P Parham,et al.  Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. , 1997, Immunity.

[2]  Eric O Long,et al.  A new human gene complex encoding the killer cell inhibitory receptors and related monocyte/macrophage receptors , 1997, Current Biology.

[3]  Nallasivam Palanisamy,et al.  Genomic organization and allelic polymorphism of the human killer cell inhibitory receptor gene KIR 103 , 1997 .

[4]  J. Trowsdale,et al.  Genomic organization of a human killer cell inhibitory receptor gene. , 1997, Tissue antigens.

[5]  L. Lanier,et al.  Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C. , 1997, Journal of immunology.

[6]  Andrew G. Brooks,et al.  NKG2A Complexed with CD94 Defines a Novel Inhibitory Natural Killer Cell Receptor , 1997, The Journal of experimental medicine.

[7]  P. Parham,et al.  Killer cell receptors: keeping pace with MHC class I evolution , 1997, Immunological reviews.

[8]  M. Carretero,et al.  The CD94 and NKG2‐A C‐type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules , 1997, European journal of immunology.

[9]  L. Lanier,et al.  Arousal and inhibition of human NK cells , 1997, Immunological reviews.

[10]  L. Lanier,et al.  Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. , 1996, Journal of immunology.

[11]  B Dupont,et al.  NK cell receptor gene of the KIR family with two IG domains but highest homology to KIR receptors with three IG domains. , 1996, Tissue antigens.

[12]  P. Parham,et al.  CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, HLA-B, and HLA-C allotypes. , 1996, Immunity.

[13]  R. Biassoni,et al.  The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer , 1996, The Journal of experimental medicine.

[14]  M. Colonna,et al.  A human killer inhibitory receptor specific for HLA-A1,2. , 1996, Journal of immunology.

[15]  P. Parham,et al.  Unexpected beta2-microglobulin sequence diversity in individual rainbow trout. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[16]  P. Parham,et al.  Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibililty complex haplotype , 1996, The Journal of experimental medicine.

[17]  Eric O Long,et al.  Inhibitory MHC class I receptors on NK and T cells: a standard nomenclature. , 1996, Immunology today.

[18]  L. Lanier,et al.  Inhibitory MHC class I receptors on NK cells and T cells. , 1996, Immunology today.

[19]  R. Biassoni,et al.  The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions , 1996, The Journal of experimental medicine.

[20]  Eric O Long,et al.  Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. , 1996, Immunity.

[21]  T. Mcclanahan,et al.  Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes. , 1995, Journal of immunology.

[22]  L. Lanier,et al.  Molecular characterization of human CD94: A type II membrane glycoprotein related to the C‐type lectin superfamily , 1995, European journal of immunology.

[23]  L. Moretta,et al.  Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells , 1995, The Journal of experimental medicine.

[24]  P. Parham,et al.  Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones , 1995, The Journal of experimental medicine.

[25]  Eric O Long,et al.  Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. , 1995, Immunity.

[26]  M. Colonna,et al.  Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. , 1995, Science.

[27]  P. Parham,et al.  The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor , 1995, The Journal of experimental medicine.

[28]  E. Adams,et al.  The Origins of HLA‐A,B,C Polymorphism , 1995, Immunological reviews.

[29]  P. Parham The rise and fall of great class I genes. , 1994, Seminars in immunology.

[30]  M. López-Botet,et al.  Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles , 1994, The Journal of experimental medicine.

[31]  P. Parham,et al.  NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules , 1994, The Journal of experimental medicine.

[32]  M. Balboa,et al.  Tyrosine kinase-dependent activation of human NK cell functions upon stimulation through a 58-kDa surface antigen selectively expressed on discrete subsets of NK cells and T lymphocytes. , 1994, Journal of immunology.

[33]  P. Parham,et al.  Structural heterogeneity in HLA-B70, a high-frequency antigen of black populations. , 1993, Tissue antigens.

[34]  P. Parham,et al.  Specificity of HLA class I antigen recognition by human NK clones: evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type , 1993, The Journal of experimental medicine.

[35]  E. Ciccone,et al.  P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities , 1993, The Journal of experimental medicine.

[36]  E. Brooks,et al.  Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C. , 1993, Science.

[37]  W. Yokoyama Recognition structures on natural killer cells. , 1993, Current opinion in immunology.

[38]  A. Amoroso,et al.  Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2) , 1992, The Journal of experimental medicine.

[39]  J. Strominger,et al.  Alloantigen recognition by two human natural killer cell clones is associated with HLA-C or a closely linked gene. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[40]  W. Yokoyama,et al.  MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells , 1992, Nature.

[41]  F. Bach,et al.  DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells , 1991, The Journal of experimental medicine.

[42]  H. Ljunggren,et al.  In search of the 'missing self': MHC molecules and NK cell recognition. , 1990, Immunology today.

[43]  P. Cresswell,et al.  NK susceptibility varies inversely with target cell class I HLA antigen expression. , 1987, Journal of immunology.

[44]  H. Ljunggren,et al.  Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy , 1986, Nature.

[45]  W. V. van Blitterswijk,et al.  Serum-free medium for generation and propagation of functional human cytotoxic and helper T cell clones. , 1984, Journal of immunological methods.